Fulgent Genetics (FLGT) Asset Utilization Ratio (2016 - 2026)
Fulgent Genetics' (FLGT) quarterly Asset Utilization Ratio came in at 0.21 in Q2 2026, down 14.86% year-over-year from 0.25 in Q2 2025, and up 7.13% quarter-over-quarter from 0.2 in Q1 2026.
Analysis
Fulgent Genetics (FLGT) Asset Utilization Ratio (2016 - 2026) Analysis & Trends
Fulgent Genetics has disclosed Asset Utilization Ratio across 11 years of filings, most recently posting 0.21 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio fell 14.86% year-over-year to 0.21; the TTM figure through Jun 2026 stood at 0.21 (down 14.86% YoY), while the FY2025 annual figure was 0.27, up 14.85% from the prior year.
- Asset Utilization Ratio came in at 0.21 for Q2 2026 at Fulgent Genetics, up from 0.2 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.69 in Q1 2022 to a low of 0.2 in Q4 2025.
- Average Asset Utilization Ratio over 5 years is 0.31, with a median of 0.24 recorded in 2023.
- Year-over-year, Asset Utilization Ratio plunged 62.55% in 2023 and increased 16.03% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.45 in 2022, then plunged by 50.97% to 0.22 in 2023, then increased by 3.61% to 0.23 in 2024, then decreased by 14.54% to 0.2 in 2025, then advanced by 8.7% to 0.21 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.21 in Q2 2026, 0.2 in Q1 2026, and 0.2 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 1.03 |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 0.69 |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 0.76 |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 0.62 |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 0.64 |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 0.83 |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 0.37 |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 0.56 |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 0.54 |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | 0.21 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.21 |
| Mar 31, 2026 | 0.20 |
| Dec 31, 2025 | 0.20 |
| Sep 30, 2025 | 0.26 |
| Jun 30, 2025 | 0.25 |
| Mar 31, 2025 | 0.24 |
| Dec 31, 2024 | 0.23 |
| Sep 30, 2024 | 0.23 |
| Jun 30, 2024 | 0.24 |
| Mar 31, 2024 | 0.23 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | 0.22 |
| Jun 30, 2023 | 0.24 |
| Mar 31, 2023 | 0.28 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | 0.56 |
| Jun 30, 2022 | 0.63 |
| Mar 31, 2022 | 0.69 |
| Dec 31, 2021 | 0.80 |
| Sep 30, 2021 | 0.92 |